INS and metabolic dysfunction-associated steatotic liver disease: TNFα stimulates lipolysis through attenuation of the insulin antilipolytic activity [6], increasing the release of free fatty acids, which are the major determinants of hepatic insulin resistance (IR) and lipogenesis, which culminates in NAFLD [49,50,52].